• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchContext Therapeutics
    Picture of Context Therapeutics logo

    CNTX — Context Therapeutics News Story

    $0.240.000.00%
    us flag iconLast trade - 00:00
    HealthcareMicro Cap
    • Market Cap
      $0.39m
    • Enterprise Value
      $121.70m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • CNTX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    CNTX Dividends
    All News

    NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:47 AM

    Picture of Context Therapeutics logoContext Therapeutics
    01/12/2021 16:47
    NASDAQ TRADE HALT  CNTX.O  VOLATILITY TRADING PAUSE AT 11:47 AM
    

    Recent news on Context Therapeutics

    See all news
    • Context Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

      05/08/2026 22:44
    • Context Therapeutics Q2 net loss widens on higher R&D costs

      05/08/2026 21:58
    • Context Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview

      31/07/2026 21:07
    • Brief: Context Therapeutics Announces Positive Interim Efficacy And Safety Results From Ongoing Phase 1 Clinical Trial For CTIM-76

      15/06/2026 11:44
    • Brief: Context Therapeutics Enters Into License Agreement Amendment With BioAtla For CT-202

      18/05/2026 11:51

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.